These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 36476159)

  • 1. Improved vascular function and functional capacity following l-citrulline administration in patients with heart failure with preserved ejection fraction: a single-arm, open-label, prospective pilot study.
    Ratchford SM; Bunsawat K; Alpenglow JK; Zhao J; Wright JB; Ryan JJ; Wray DW
    J Appl Physiol (1985); 2023 Feb; 134(2):328-338. PubMed ID: 36476159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of microvascular dysfunction in heart failure with preserved ejection fraction.
    Lee JF; Barrett-O'Keefe Z; Garten RS; Nelson AD; Ryan JJ; Nativi JN; Richardson RS; Wray DW
    Heart; 2016 Feb; 102(4):278-84. PubMed ID: 26567228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of acute antioxidant administration on inflammation and vascular function in heart failure with preserved ejection fraction.
    Ratchford SM; Clifton HL; Gifford JR; LaSalle DT; Thurston TS; Bunsawat K; Alpenglow JK; Richardson RS; Wright JB; Ryan JJ; Wray DW
    Am J Physiol Regul Integr Comp Physiol; 2019 Nov; 317(5):R607-R614. PubMed ID: 31483155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sacubitril-valsartan improves conduit vessel function and functional capacity and reduces inflammation in heart failure with reduced ejection fraction.
    Bunsawat K; Ratchford SM; Alpenglow JK; Park SH; Jarrett CL; Stehlik J; Smith AS; Richardson RS; Wray DW
    J Appl Physiol (1985); 2021 Jan; 130(1):256-268. PubMed ID: 33211601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide metabolites: associations with cardiovascular biomarkers and clinical parameters in patients with HFpEF.
    Piatek K; Feuerstein A; Zach V; Rozados da Conceicao C; Beblo A; Belyavskiy E; Pieske-Kraigher E; Krannich A; Schwedhelm E; Hinz S; Pieske B; Edelmann F
    ESC Heart Fail; 2022 Dec; 9(6):3961-3972. PubMed ID: 35979962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of endurance exercise training on endothelial function and arterial stiffness in older patients with heart failure and preserved ejection fraction: a randomized, controlled, single-blind trial.
    Kitzman DW; Brubaker PH; Herrington DM; Morgan TM; Stewart KP; Hundley WG; Abdelhamed A; Haykowsky MJ
    J Am Coll Cardiol; 2013 Aug; 62(7):584-92. PubMed ID: 23665370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow-Mediated Vasodilation and Reactive Hyperemia Index in Heart Failure with Reduced or Preserved Ejection Fraction.
    Waku R; Tokoi S; Toyoda S; Kitahara K; Naganuma J; Yazawa H; Sakuma M; Abe S; Nakajima T; Inoue T
    Tohoku J Exp Med; 2020 Sep; 252(1):85-93. PubMed ID: 32893258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined Citrulline and Glutathione Supplementation Improves Endothelial Function and Blood Pressure Reactivity in Postmenopausal Women.
    Figueroa A; Maharaj A; Kang Y; Dillon KN; Martinez MA; Morita M; Nogimura D; Fischer SM
    Nutrients; 2023 Mar; 15(7):. PubMed ID: 37049398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between exercise intervention and NO pathway in patients with heart failure with preserved ejection fraction.
    Baldassarri F; Schwedhelm E; Atzler D; Böger RH; Cordts K; Haller B; Pressler A; Müller S; Suchy C; Wachter R; Düngen HD; Hasenfuss G; Pieske B; Halle M; Edelmann F; Duvinage A
    Biomarkers; 2018 Sep; 23(6):540-550. PubMed ID: 29619838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial dysfunction and abnormal vascular structure are simultaneously present in patients with heart failure with preserved ejection fraction.
    Kishimoto S; Kajikawa M; Maruhashi T; Iwamoto Y; Matsumoto T; Iwamoto A; Oda N; Matsui S; Hidaka T; Kihara Y; Chayama K; Goto C; Aibara Y; Nakashima A; Noma K; Higashi Y
    Int J Cardiol; 2017 Mar; 231():181-187. PubMed ID: 28082090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart failure with preserved vs reduced ejection fraction following cardiac rehabilitation: impact of endothelial function.
    Tanaka S; Sanuki Y; Ozumi K; Harada T; Tasaki H
    Heart Vessels; 2018 Aug; 33(8):886-892. PubMed ID: 29392470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between noninvasive upper- and lower-limb vascular function assessments: extending the evidence to young women.
    D'Agata MN; Hoopes EK; Witman MA
    J Appl Physiol (1985); 2022 Oct; 133(4):886-892. PubMed ID: 36007894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
    Paulus WJ; Tschöpe C
    J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular responses to rhythmic handgrip exercise in heart failure with preserved ejection fraction.
    Ratchford SM; Clifton HL; La Salle DT; Broxterman RM; Lee JF; Ryan JJ; Hopkins PN; Wright JB; Trinity JD; Richardson RS; Wray DW
    J Appl Physiol (1985); 2020 Dec; 129(6):1267-1276. PubMed ID: 32940557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does l-citrulline supplementation improve exercise blood flow in older adults?
    Gonzales JU; Raymond A; Ashley J; Kim Y
    Exp Physiol; 2017 Dec; 102(12):1661-1671. PubMed ID: 28940638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular and Microvascular Endothelial Function in Heart Failure With Preserved Ejection Fraction.
    Maréchaux S; Samson R; van Belle E; Breyne J; de Monte J; Dédrie C; Chebai N; Menet A; Banfi C; Bouabdallaoui N; Le Jemtel TH; Ennezat PV
    J Card Fail; 2016 Jan; 22(1):3-11. PubMed ID: 26386451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction.
    Dryer K; Gajjar M; Narang N; Lee M; Paul J; Shah AP; Nathan S; Butler J; Davidson CJ; Fearon WF; Shah SJ; Blair JEA
    Am J Physiol Heart Circ Physiol; 2018 May; 314(5):H1033-H1042. PubMed ID: 29424571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of L-arginine and citrulline on endothelial function in patients in heart failure with preserved ejection fraction.
    Orea-Tejeda A; Orozco-Gutiérrez JJ; Castillo-Martínez L; Keirns-Davies C; Montano-Hernández P; Vázquez-Díaz O; Valdespino-Trejo A; Infante O; Martínez-Memije R
    Cardiol J; 2010; 17(5):464-70. PubMed ID: 20865676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of L-arginine or L-citrulline oral supplementation on blood pressure and right ventricular function in heart failure patients with preserved ejection fraction.
    Orozco-Gutiérrez JJ; Castillo-Martínez L; Orea-Tejeda A; Vázquez-Díaz O; Valdespino-Trejo A; Narváez-David R; Keirns-Davis C; Carrasco-Ortiz O; Navarro-Navarro A; Sánchez-Santillán R
    Cardiol J; 2010; 17(6):612-8. PubMed ID: 21154265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of obesity on the regulation of muscle blood flow during exercise in patients with heart failure with a preserved ejection fraction.
    Ratchford SM; Lee JF; Bunsawat K; Alpenglow JK; Zhao J; Ma CL; Ryan JJ; Khor LL; Wray DW
    J Appl Physiol (1985); 2022 May; 132(5):1240-1249. PubMed ID: 35421322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.